Cover Image
市場調查報告書

醫藥品的全球市場

Pharmaceutical Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531323
出版日期 內容資訊 英文 455 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品的全球市場 Pharmaceutical Drugs Global Market Report 2018
出版日期: 2018年03月14日 內容資訊: 英文 455 Pages
簡介

本報告提供全球醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各疾病部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 心血管系統醫藥品
    • 皮膚科醫藥品
    • 消化器官系統醫藥品
    • 泌尿生殖系統系醫藥品
    • 血液用醫藥品
    • 感染疾病用醫藥品
    • 代謝性疾病用醫藥品
    • 肌肉骨骼障礙用醫藥品
    • 中樞神經系統醫藥品
    • 癌症用醫藥品
    • 眼科用醫藥品
    • 呼吸系統醫藥品
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略
  • 與類似市場的實際成果比較
  • 與類似市場的實際成果·預測比較
  • 與類似市場的實際成果比較:各地區
  • 與類似市場的實際成果比較:各國
  • 治療性蛋白質
  • 心血管疾病
  • 皮膚科
  • 消化器官系統疾病
  • 泌尿生殖系統系疾病
  • 血液
  • 感染疾病
  • 代謝性疾病
  • 肌肉骨骼障礙
  • 中樞神經系統
  • 癌症
  • 眼科
  • 呼吸系統疾病

第6章 醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫療保健市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫療保健市場實際成果:部門·各國
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Johnson & Johnson
  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi

第18章 主要M&A

第19章 市場背景:醫藥品市場

第20章 醫療保健產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Pharmaceutical drugs are intended for human or veterinary use presented in their finished dosage form.

The North America pharmaceutical drugs market is worth $341.1 billion, and is the largest in the world. It currently has about 36.5% share of the global pharmaceutical drugs market. This was mainly due to the presence of major pharmaceutical companies, increasing patent expirations and improved access to affordable healthcare in the region. The pharmaceutical drugs market in Asia-Pacific is the second largest in the world; it currently has about 21.5% of the global pharmaceutical drugs market.

Musculoskeletal Disorders Drugs was the largest segment in the global pharmaceutical drugs market in 2017, accounting for about 14% of the market. Metabolic Disorders Drugs had the highest CAGR of 11.6% during 2013-2017; this segment is expected to grow at a CAGR of 9% during 2017-2021. Other segments covered in the report include cardiovascular drugs, oncology drugs, anti-infective drugs, central nervous system drugs, genito-urinary drugs, respiratory diseases drugs, gastrointestinal drugs, hematoloty drugs, dermatology drugs, ophthalmology drugs.

The increasing shift from prescription to non-prescription drugs, growing development of personalized medicine and moving away from animal testing methods are some of the major trends in the pharmaceutical industry. There has been an increasing push towards the development of personalized medicine. Personalized medicine is also referred to as precision medicine, the idea of which is to provide medical care according to patient's individual characteristics, needs, preferences and genetic makeup. According to a survey by the Tufts Center, 94% of pharmaceutical companies have invested in personal medicine research. For instance, Roche through its drug and diagnostics approach to cancer, HER2-positive therapies generated about $20 billion in sales.

The market for pharmaceutical drugs is highly competitive. Novartis AG was the largest player with 4.5% share in the global pharmaceutical drugs market in 2017, followed by Sanofi S.A., F. Hoffman-La Roche Ltd., Pfizer Inc. and Gilead Sciences Inc.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.

Description

Where is the largest and fastest growing market for pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs global market report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints cover the external factors supporting and controlling the growth of the market.
  • PESTLE Analysis covers the political, economic, social, technological, legal and environmental factors affecting the pharmaceutical drugs market.
  • The customer information section covers major surveys conducted on the global pharmaceutical drugs market and their implications.
  • Market segmentations break down market into sub markets, including Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs and Ophthalmology Drugs. The historic and forecast growth rates for these segments are also covered in this report.
  • A comparison of the pharmaceutical drugs market with macro-economic factors and industry metrics is also covered in the report.
  • The regional and country breakdown section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets.
  • The competitive landscape section gives a description of the competitive nature of the market, market shares, and a description of the leading companies in terms of their offerings, growth strategy and financial performance.
  • The report also covers key mergers and acquisitions in the pharmaceutical drugs market. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets covered: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs.

Companies mentioned: Novartis AG, Sanofi S.A., F. Hoffman-La Roche Ltd., Pfizer Inc. and Gilead Sciences Inc.

Countries: China, Japan, India, Australia, USA, Brazil, UK, Germany, France, Spain, Italy, Russia, South Africa

Regions: Asia-Pacific, North America, South America, Western Europe, Eastern Europe, Middle East and Africa.

Time series: Five years historic and forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Executive Summary 28

Pharmaceutical Drugs Market Characteristics 29

Global Pharmaceutical Drugs Market Size And Growth 31

Global Pharmaceutical Drugs Historic Market Growth 31

Drivers Of The Market 33

Restraints On The Market 33

Global Pharmaceutical Drugs Market Forecast Growth 35

Drivers Of The Market 36

Restraints On The Market 37

Global Pharmaceutical Drugs Market, PESTLE Analysis 38

Political 38

Economic 39

Social 39

Technological 40

Legal 40

Environmental 40

Pharmaceutical Drugs Market Customer Information 42

Survey on Prescription Drugs 42

Americans Taking More Prescription Drugs than Ever: Survey 42

Increasing Intake of Prescription Drugs 42

Consumers Find Generics As Good As Prescription Drugs 42

Pharmaceutical Drugs Market Regional And Country Analysis 43

Pharmaceutical Drugs Market, 2017, Split By Region 43

Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Region 45

Pharmaceutical Drugs Market, 2017, Split By Country 46

Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Country 49

Global Pharmaceutical Drugs Market Segmentation 51

Global Pharmaceutical Drugs Market, Split By Segments, 2017, $ Billion 51

Musculoskeletal Disorders Drugs 52

Cardiovascular Drugs 52

Oncology Drugs 53

Anti-infective Drugs 53

Metabolic Disorder Drugs 53

Central Nervous System Drugs 53

Genito-urinary Drugs 54

Respiratory Drugs 54

Gastrointestinal Drugs 54

Hematology Drugs 54

Dermatology Drugs 54

Ophthalmology Drugs 54

Global Pharmaceutical Drugs Market, 2013-2017, Historic And Forecast Growth Rate, Split By Segments 55

Pharmaceutical Drugs Market Segments And Subsegments 58

Musculoskeletal Disorders Drugs 58

Musculoskeletal Disorders Drugs Market Characteristics 58

Musculoskeletal Disorders Drugs Market Trends & Strategies 60

Global Musculoskeletal Disorders Drugs Market, By Subsegment 61

Drugs for Rheumatoid Arthritis 61

Muscle Relaxants 61

Others 61

Global Musculoskeletal Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 62

Global Musculoskeletal Drugs Market Competitive Landscape 63

F.Hoffmann-La Roche 65

GlaxoSmithKline 65

Pfizer 66

Global Musculoskeletal Drugs Market Key Mergers And Acquisitions 68

Cardiovascular Drugs 69

Cardiovascular Drugs Market Characteristics 69

Cardiovascular Drugs Market Trends & Strategies 71

Global Cardiovascular Drugs Market, Segmentation By Subsegment 73

Anti-hypertensive Drugs 73

Hypolipidemics 74

Anti Thrombotics 74

Other Drugs For Cardiovascular Diseases 74

Global Cardiovascular Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 74

Global Cardiovascular Drugs Market Competitive Landscape 75

Sanofi 77

Merck & Co. 77

Pfizer 78

Global Cardiovascular Drugs Market Key Mergers And Acquisitions 79

Oncology Drugs 80

Oncology Drugs Market Characteristics 80

Oncology Drugs Market Trends & Strategies 82

Global Oncology Drugs Market, Segmentation By Subsegment 82

Blood Cancer 84

Breast Cancer 84

Cervical Cancer 84

Lung Cancer 84

Colorectal Cancer 84

Non-Small Cell Lung Cancer 84

Prostate Cancer 84

Kidney Cancer 84

Gastric Cancer 85

Brain Tumor 85

Pancreatic Cancer 85

Skin Cancer 85

Ovarian Cancer 85

Bladder Cancer 85

Thyroid Cancer 85

Others 85

Global Oncology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 86

Global Oncology Drugs Market Competitive Landscape 88

F.Hoffmann-La Roche 89

Novartis 90

Gilead Sciences, Inc. 90

Global Oncology Drugs Market Key Mergers And Acquisitions 92

Anti-Infective Drugs 94

Anti-infective Drugs Market Characteristics 94

Anti-infective Drugs Market Trends & Strategies 96

Global Anti-Infective Drugs Market, Segmentation By Subsegment 97

Antivirals 97

Antibiotics 97

Antifungals 97

Antiparasitic (Antihelmethic, Antiprotozoal) 98

Global Anti-Infective Drugs Market, 2013-2017, Historic And Forecast Growth Rates, By Subsegment 98

Global Anti-Infective Drugs Market Competitive Landscape 101

Gilead 102

Merck & Co. 103

GlaxoSmithKline 103

Global Anti-Infective Drug Market Key Mergers and Acquisitions 104

Metabolic Disorders Drugs 106

Metabolic Disorders Drugs Market Characteristics 106

Metabolic Disorders Drugs Market Trends & Strategies 108

Global Metabolic Disorders Drugs Market, Segmentation By Subsegment 109

Anti-diabetics Drugs 109

Anti-thyroid drugs 109

Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism) 109

Global Metabolic Disorders Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 110

Global Metabolic Disorder Drugs Market Competitive Landscape 112

Sanofi 113

AstraZeneca PLC 113

Global Metabolic Disorders Drugs Market Key Mergers And Acquisitions 114

Central Nervous System Drugs 116

Central Nervous System Drugs Market Characteristics 116

Central Nervous System Drugs Market Trends & Strategies 117

Global Central Nervous System Drugs Market, Segmentation By Subsegment 119

Anesthetics 119

Analgesics 120

Anti-Parkinson drugs 120

Anti-Epileptics 120

Other CNS drugs 120

Global Central Nervous System Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 120

Global Central Nervous System Market Competitive Landscape 122

Biogen Idec 124

F. Hoffmann-La Roche 124

Johnson & Johnson (J&J) 125

Global Central Nervous System Drugs Market Key Mergers And Acquisitions 126

Genito-Urinary Drugs 128

Genito-Urinary Drugs Market Characteristics 128

Genito-Urinary Drugs Market Trends & Strategies 130

Global Genito-Urinary Drugs Market, Segmentation By Subsegment 131

Hormonal Contraceptives 132

Drugs For Hormonal Replacement Therapy 132

Drugs For Infections And Others 132

Drugs for Benign Prostatic Hypertrophy was 132

Drugs For Erectile Dysfunction 132

Drugs For Urinary Incontinence And Overactive Bladder 132

Drugs for Infertility 132

Diuretics 132

Global Genito-Urinary Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Segment 133

Global Genito-Urinary Drugs Market Competitive Landscape 135

Daiichi Sankyo Company Limited 136

Pfizer 137

Bayer AG 137

Genito-urinary Drugs Market Key Mergers And Acquisitions 139

Respiratory Diseases 140

Respiratory Diseases Drugs Market Characteristics 140

Respiratory Diseases Drugs Market Trends & Strategies 142

Global Respiratory Diseases Market, Segmentation By Subsegment 144

Anti-Asthmatics And COPD Drugs 144

Cough And Cold Preparations 144

Global Respiratory Diseases Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 145

Global Respiratory Diseases Drugs Market Competitive Landscape 146

GlaxoSmithKline 147

AstraZeneca PLC 148

Merck & Co. 149

Global Respiratory Drugs Market Key Mergers And Acquisitions 149

Gastrointestinal Drugs 150

Gastrointestinal Drugs Market Characteristics 150

Gastrointestinal Drugs Market Trends & Strategies 152

Global Gastrointestinal Drugs Market, Segmentation By Subsegment 152

Antiulcerants 153

Vitamins And Minerals 154

Antacids 154

Antiemetics And Antinauseants 154

Antiobesity 154

Antidiarrhoeals 154

Global Gastrointestinal Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 154

Global Gastrointestinal Drugs Market Competitive Landscape 156

Takeda Pharmaceuticals 157

Allergan 158

Global Gastrointestinal Drugs Market Key Mergers And Acquisitions 159

Hematology Drugs 161

Hematology Drugs Market Characteristics 161

Hematology Drugs Market Trends & Strategies 163

Global Hematology Drugs Market, Segmentation By Subsegment 165

Blood Products 165

Anemia And Other Blood Disorder Drugs 165

Global Hematology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 166

Global Hematology Drugs Market Competitive Landscape 167

Shire Plc. 168

Bayer AG 168

Global Hematology Drugs Market Key Mergers And Acquisitions 170

Dermatology Drugs 171

Dermatology Drugs Market Characteristics 171

Dermatology Drugs Market Trends & Strategies 173

Global Dermatology Drugs Market Competitive Landscape 175

Johnson & Johnson (J&J) 176

Allergan 176

Galderma S.A. 177

Dermatology Drugs Market Key Mergers And Acquisitions 179

Ophthalmology Drugs 181

Ophthalmology Drugs Market Characteristics 181

Ophthalmology Drugs Market Trends & Strategies 183

Global Ophthalmology Drugs Market, Segmentation By Subsegment 184

Antiglaucoma 184

Dry Eye Medication 185

Other Opthalmological Drugs 185

Global Ophthalmology Drugs Market, 2013-2017, Historic And Forecast Growth Rate, By Subsegment 186

Global Ophthalmology Drugs Market Competitive Landscape 187

Novartis AG 188

F.Hoffmann-La Roche 189

Allergan 189

Ophthalmology Drugs Market Key Mergers And Acquisitions 191

Pharmaceutical Drugs Market Comparison With Macro Economic Factors 193

Pharmaceutical Drugs Market Size And Percentage Of GDP, Global 193

Per Capita Average Pharmaceutical Drugs Expenditure, Global 194

Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries 195

Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country 195

Per Capita Average Pharmaceutical Drugs Expenditure, By Country 196

Pharmaceutical Drugs Market Comparison With Industry Metrics 198

Number Of General Practitioners 2017, By Country 198

Average Pharmaceutical Drugs Revenue Per General Practitioner, 2017, By Country 200

Number Of Pharmacies Per 100,000 Population, 2017, By Country 201

Number Of Pharmacists, 2017, By Country 202

Average Pharmaceutical Drugs Revenue Per Pharmacist, 2017, By Country 203

Number Of Employees In Pharmaceutical Industry, 2017, By Country 204

Average Revenue Per Pharmaceutical Employee, 2017, By Country 206

Number Of Pharmaceutical Enterprises, 2017, By Country 207

Average Pharmaceutical Drugs Revenue Per Pharmaceutical Enterprise, 2017, By Country 208

Generic & Branded Sales Proportion By Country (Value), 2016, By Country 211

New Drug Approvals, 2017, By Country 212

Pharmaceutical Market By Region And Country 214

Asia-Pacific Pharmaceutical Drugs Market 214

Asia-Pacific Pharmaceutical Drugs Market Overview 214

Region Information 214

Market Information 214

New Drug Trials And Approvals 214

Regulations 214

Regulatory Bodies 215

Associations 216

Government Initiatives 216

Investments 216

Competitive Landscape 217

Asia Pacific Pharmaceutical Market 218

Asia Pacific Pharmaceutical Drugs Historic Market Growth 218

Asia Pacific Pharmaceutical Drugs Market Forecast Growth 220

Asia Pacific Pharmaceutical Drugs Market, Segmentation By Type 221

Asia Pacific Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 222

Asia-Pacific Pharmaceutical Drugs Market: Country Analysis 225

China Pharmaceutical Drugs Market 225

China Pharmaceutical Drugs Market Overview 226

China Pharmaceutical Market 229

China Pharmaceutical Drugs Historic Market Growth 229

China Pharmaceutical Drugs Market Forecast Growth 231

China Pharmaceutical Drugs Market, Segmentation By Type 232

China Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 233

India Pharmaceutical Drugs Market 235

India Pharmaceutical Drugs Market Overview 236

India Pharmaceutical Market 239

India Pharmaceutical Drugs Historic Market Growth 239

India Pharmaceutical Drugs Market Forecast Growth 241

India Pharmaceutical Drugs Market, Segmentation By Type 242

India Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 243

Japan Pharmaceutical Drugs Market 245

Japan Pharmaceutical Drugs Market Overview 245

Japan Pharmaceutical Market 249

Japan Pharmaceutical Drugs Historic Market Growth 249

Japan Pharmaceutical Drugs Market Forecast Growth 251

Japan Pharmaceutical Drugs Market, Segmentation By Type 252

Japan Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 253

Australia Pharmaceutical Drugs Market 255

Australia Pharmaceutical Market 255

Australia Pharmaceutical Drugs Historic Market Growth 255

Australia Pharmaceutical Drugs Market Forecast Growth 257

Australia Pharmaceutical Drugs Market, Segmentation By Type 258

Australia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 259

Western Europe Pharmaceutical Drugs Market 262

Western Europe Pharmaceutical Drugs Market Overview 262

Region Information 262

Market Information 262

New Drug Trials And Approvals 262

Regulations 262

Regulatory Bodies 263

Associations 263

Government Initiatives 263

Investments 263

Competitive Landscape 264

Western Europe Pharmaceutical Market 265

Western Europe Pharmaceutical Drugs Historic Market Growth 265

Western Europe Pharmaceutical Drugs Market Forecast Growth 267

Western Europe Pharmaceutical Drugs Market, Segmentation By Type 268

Western Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 269

Western Europe Pharmaceutical Drugs Market: Country Analysis 271

UK Pharmaceutical Drugs Market 272

UK Pharmaceutical Drugs Market Overview 272

UK Pharmaceutical Market 274

UK Pharmaceutical Drugs Historic Market Growth 274

UK Pharmaceutical Drugs Market Forecast Growth 276

UK Pharmaceutical Drugs Market, Segmentation By Type 277

UK Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 278

Germany Pharmaceutical Drugs Market 280

Germany Pharmaceutical Market 280

Germany Pharmaceutical Market 281

Germany Pharmaceutical Drugs Historic Market Growth 281

Germany Pharmaceutical Drugs Market Forecast Growth 283

Germany Pharmaceutical Drugs Market, Segmentation By Type 284

Germany Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 285

France Pharmaceutical Drugs Market 287

France Pharmaceutical Market 287

France Pharmaceutical Market 288

France Pharmaceutical Drugs Market Forecast Growth 289

France Pharmaceutical Drugs Market, Segmentation By Type 290

France Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 291

Italy Pharmaceutical Drugs Market 293

Italy Pharmaceutical Market 293

Italy Pharmaceutical Market 294

Italy Pharmaceutical Drugs Historic Market Growth 294

Italy Pharmaceutical Drugs Market Forecast Growth 296

Italy Pharmaceutical Drugs Market, Segmentation By Type 297

Italy Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 298

Spain Pharmaceutical Drugs Market 300

Spain Pharmaceutical Market 300

Spain Pharmaceutical Market 301

Spain Pharmaceutical Drugs Historic Market Growth 301

Spain Pharmaceutical Drugs Market Forecast Growth 303

Spain Pharmaceutical Drugs Market, Segmentation By Type 304

Spain Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 305

Eastern Europe Pharmaceutical Drugs Market 308

Eastern Europe Pharmaceutical Drugs Market Overview 308

Region Information 308

Market Information 308

New Drug Trials And Approvals 308

Regulations 308

Regulatory Bodies 309

Associations 309

Government Initiatives 309

Investments 309

Competitive Landscape 309

Eastern Europe Pharmaceutical Market 310

Eastern Europe Pharmaceutical Drugs Historic Market Growth 310

Eastern Europe Pharmaceutical Drugs Market Forecast Growth 312

Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type 313

Eastern Europe Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rate, Segmentation By Type 314

Eastern Europe Pharmaceutical Drugs Market: Country Analysis 316

Russia Pharmaceutical Drugs Market 316

Russia Pharmaceutical Market 316

Russia Pharmaceutical Market 317

Russia Pharmaceutical Drugs Market Forecast Growth 318

Russia Pharmaceutical Drugs Market, Segmentation By Type 319

Russia Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 321

North America Pharmaceutical Drugs Market 323

North America Pharmaceutical Drugs Market Overview 323

Region Information 323

Market Information 323

New Drug Trials And Approvals 323

Regulations 323

Regulatory Bodies 324

Associations 324

Government Initiatives 324

Investments 324

Competitive Landscape 325

North America Pharmaceutical Market 326

North America Pharmaceutical Drugs Historic Market Growth 326

North America Pharmaceutical Drugs Market Forecast Growth 328

North America Pharmaceutical Drugs Market, Segmentation By Type 329

North America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 330

North America Pharmaceutical Drugs Market: Country Analysis 332

USA Pharmaceutical Drugs Market 332

USA Pharmaceutical Drugs Market Overview 332

USA Pharmaceutical Market 335

USA Pharmaceutical Drugs Historic Market Growth 335

USA Pharmaceutical Drugs Market Forecast Growth 337

USA Pharmaceutical Drugs Market, Segmentation By Type 338

USA Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 339

South America Pharmaceutical Drugs Market 342

South America Pharmaceutical Drugs Market Overview 342

Region Information 342

Market Information 342

General Information 342

Regulations 342

Regulatory Bodies 343

Associations 343

Government Initiatives 343

Investments 343

Competitive Landscape 344

South America Pharmaceutical Market 345

South America Pharmaceutical Drugs Historic Market Growth 345

South America Pharmaceutical Drugs Market Forecast Growth 347

South America Pharmaceutical Drugs Market, Segmentation By Type 348

South America Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 349

South America Pharmaceutical Drugs Market: Country Analysis 351

Brazil Pharmaceutical Drugs Market 351

Brazil Pharmaceutical Market 351

Brazil Pharmaceutical Drugs Historic Market Growth 351

Brazil Pharmaceutical Drugs Market Forecast Growth 353

Brazil Pharmaceutical Drugs Market, Segmentation By Type 354

Brazil Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 355

Middle East Pharmaceutical Drugs Market 357

Middle East Pharmaceutical Drugs Market Overview 357

Region Information 357

Market Information 357

New Drug Trials And Approvals 358

Regulations 358

Regulatory Bodies 358

Government Initiatives 358

Investments 358

Competitive Landscape 359

Middle East Pharmaceutical Market 360

Middle East Pharmaceutical Drugs Historic Market Growth 360

Middle East Pharmaceutical Drugs Market Forecast Growth 362

Middle East Pharmaceutical Drugs Market, Segmentation By Type 363

Middle East Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 365

Africa Pharmaceutical Drugs Market 367

Africa Pharmaceutical Drugs Market Overview 367

Region Information 367

Market Information 367

New Drug Trials And Approvals 367

Regulations 367

Regulatory Bodies 368

Associations 368

Government Initiatives 368

Investments 368

Competitive Landscape 368

Africa Pharmaceutical Market 369

Africa Pharmaceutical Drugs Historic Market Growth 369

Africa Pharmaceutical Drugs Market Forecast Growth 371

Africa Pharmaceutical Drugs Market, Segmentation By Type 372

Africa Pharmaceutical Drugs Market, 2013 - 2021, Historic And Forecast Growth Rates, Segmentation By Type 374

Global Pharmaceutical Drugs Market Competitive Landscape 376

Novartis AG 377

Sanofi S.A. 377

F. Hoffmann-La Roche Ltd. 377

Pfizer Inc. 377

Gilead Sciences, Inc. 377

Johnson & Johnson 377

GlaxosmithKline Plc. 377

Bayer AG 377

Teva Pharmaceuticals 377

Merck & Co. 377

Company Profiles 377

Novartis AG 377

Company Overview 378

Products And Services 378

Strategy 378

Novartis AG Financial Performance 379

Sanofi 380

Company Overview 380

Products And Services 380

Strategy 380

Sanofi S.A Financial Performance 380

F. Hoffmann-La Roche Ltd 382

Company Overview 382

Products And Services 382

Strategy 382

F. Hoffmann-La Roche Ltd Financial Performance 383

Pfizer Inc. 384

Company Overview 384

Products And Services 384

Strategy 384

Pfizer Inc. Financial Performance 384

Gilead Sciences Inc. 385

Company Overview 385

Products And Services 386

Strategy 386

Gilead Sciences Inc. Financial Performance 386

Key Mergers And Acquisitions In The Pharmaceutical Drugs Market 388

Actavis Plc. Acquired Allergan Inc. 388

Teva Acquired Allergan's Generic Business 388

AbbVie Acquired Pharmacyclics 388

Pfizer Acquired Hospira 389

Pfizer Acquired Medivation 390

Bayer Acquired Merck's Consumer Care Business 390

Valeant Pharmaceuticals International Acquired Salix Pharmaceuticals 390

Endo International plc Acquired Par Pharmaceutical Holdings Inc. 390

Alexion Acquired Synageva 390

Roche Acquired InterMune 390

Celgene Acquired Receptos 390

Shire Acquired Dyax Corp. 391

AbbVie Acquired Stemcentrx 391

ADMA Biologics Acquired Biotest's Therapy Business 391

Pharmaceutical Drugs Market Trends And Strategies 392

Early Rx-To-OTC Switch 392

Demand For New Medicines For Drug-Resistant Infections 392

Turning Away From Animal Testing 392

Increase In Personalized Medicine 393

Collaboration Driving Innovation 393

Increase in Mergers and Acquisitions 393

Aggressive Pricing Changes in Some Drugs 393

Market Background: Healthcare Market 394

Healthcare Market Characteristics 394

Global Healthcare Historic Market Growth 396

Drivers Of The Market 397

Restraints On The Market 398

Global Healthcare Forecast Market Growth 399

Drivers Of The Market 400

Restraints On The Market 401

Healthcare Market Geography Regional And Country Analysis 402

Healthcare Market, 2017, By Region 402

Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Region 404

Healthcare Market, 2017, By Country 406

Healthcare Market, 2013 - 2021, Historic And Forecast Growth Rates, By Country 408

Healthcare Market Segmentation, By Region, 2017 410

Healthcare Market Segmentation, By Country, 2017 411

Global Healthcare Market Comparison With Macro Economic Factors 413

Global Healthcare Market Size, Percentage Of GDP 413

Global Per Capita Average Healthcare Expenditure 414

Healthcare Market Comparison With Macro Economic Factors Across Countries 415

Healthcare Market Size, Percentage Of GDP, By Country 415

Per Capita Average Healthcare Expenditure, By Country 417

Key Mergers And Acquisitions In The Healthcare Market 418

Healthcare Market Trends And Strategies 420

Digitalization Of Medical Records 420

Shared Medical Appointments 420

Personalized Health 420

Increase in Mergers and Acquisitions 420

Appendix 421

Market Data Sources 421

Research Methodology 421

Note on Currency Conversions 422

Research Inquiries 422

The Business Research Company 422

Copyright and Disclaimer 423

Back to Top